Ashley Genty

Recommended Articles

• This Combination of Medications May Help Ease Sleep Apnea Symptoms

  Sleep apnea causes you to stop breathing briefly dozens of times every night. It is a serious condition that causes daytime fatigue, high blood pressure, and heart problems. Having sleep apnea also increases your risk of insulin resistance, also known as type 2 diabetes. If you are unable to sleep...

• A Guide to Surviving the First Year of Nursing

  There are really no ways to describe all those feelings that a newly graduated nurse can feel.  From the pride of successfully reaching a goal to the excitement of landing that first nursing job and finally, the nervous jitters that come along with treating a patient for the first time as a...

• What is HIV: Get the Facts

  Over the course of our four million or so years of evolution, we humans have developed a highly-specialized immune system that is quite a warrior in combating infections. We are bombarded daily by bacterial and viral pathogens which have the potential to cause us serious illness, but, completely...

• A Cure for Crohn’s. How Hopeful Should We Be?

  In the United States alone, over 780,000 individuals are living with Crohn’s disease, a chronic inflammatory bowel disease that affects the entire digestive tract. To this day, it remains a painful, debilitating, and complex disease for which a cure has yet to be found. But now, research has...

• Does Celiac Disease Impact Hair Growth?

  As celiac disease (CD) continues to be a hot topic, more people are becoming to understand its many symptoms. Everyone knows that CD can cause gastrointestinal problems, headaches, skin issues, and weight loss. But, with all the ‘common’ and well-known symptoms, there is also a few not-so-well...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...